株式会社免疫生物研究所
Ranked #2,940 among listed Japanese companies by corporate taxes paid · effective tax rate -9.5%.
Share price at fiscal year-end: ¥1,342 · market capitalization ¥12.5B · P/E 38.0 · P/B 6.78
US dollar amounts use ¥157.8 per dollar.
| Fiscal year | Revenue | Net income | Tax expense | Taxes paid | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|---|---|
| Mar 2026 | ¥1.0B | ¥329M | −¥28.5M | ¥5.5M | ¥2.2B | ¥1.8B | 85.5% | EDINET (consol.) |
| Mar 2025 | ¥970M | ¥249M | −¥39.2M | ¥5.9M | ¥1.8B | ¥1.5B | 82.1% | EDINET (consol.) |
| Mar 2024 | ¥817M | ¥187M | — | — | ¥1.6B | ¥1.3B | 78.2% | EDINET (consol.) |
| Mar 2023 | ¥795M | −¥290M | — | — | ¥1.4B | ¥1.1B | 75.2% | EDINET (consol.) |
| Mar 2022 | ¥648M | −¥259M | — | — | ¥1.7B | ¥1.4B | 80.2% | EDINET (consol.) |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.